4.7 Article

Hypertension Across a Woman's Life Cycle

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 71, Issue 16, Pages 1797-1813

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.02.033

Keywords

hypertension; pregnancy-related hypertension; prevention; race and ethnicity; women

Funding

  1. National Heart, Lung, and Blood Institute (NHLBI) [N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164, RO1-HL-073412-01, U0164829, U01 HL649141, U01 HL649241]
  2. Gustavus and Louis Pfeiffer Research Foundation
  3. Women's Guild of Cedars-Sinai Medical Center
  4. Ladies Hospital Aid Society of Western Pennsylvania
  5. QMED, Inc. (Laurence Harbor, New Jersey)
  6. Edythe L. Broad Endowment
  7. Barbra Streisand Women's Cardiovascular Research and Education Program
  8. Linda Joy Pollin Women's Heart Health Program
  9. Cedars-Sinai Medical Center
  10. Emory Women's Heart Center, Emory University School of Medicine
  11. Alnylam Pharmaceuticals
  12. Gilead Sciences
  13. NHLBI
  14. Pfizer
  15. Society for Women's Health Research
  16. National Institutes of Health Pharmacogenomics Research Network [U01-GM074492]
  17. Boehringer Ingelheim
  18. Gatorade Trust through University of Florida, Department of Medicine
  19. Gatorade Trust through National Institutes of Health, National Center for Advancing Translational Sciences-University of Florida Clinical and Translational Science [UL1TR001427]
  20. Gatorade Trust through PCORnet-OneFlorida Clinical Research Consortium [CDRN-1501-26692]
  21. Gatorade Trust through U.S. Department of Defense [CDMRP PR161603]
  22. Adelphi Values
  23. Amgen
  24. AstraZeneca
  25. Athersys
  26. Brigham and Women's Hospital
  27. Capricor Inc.
  28. Cytori Therapeutics
  29. Daiichi-Sankyo
  30. Department of Defense
  31. Duke University
  32. Gilead Sciences, Inc.
  33. inVentive Health Clinical LLC
  34. Merck Co.
  35. National Institutes of Health/NHLBI
  36. Minocycline HTN
  37. Microbiota HTN
  38. Microbiota
  39. Relypsa
  40. Sanofi

Ask authors/readers for more resources

Hypertension accounts for 1 in 5 deaths among American women, posing a greater burden for women than men, and is among their most important risk factors for death and development of cardiovascular and other diseases. Hypertension affects women in all phases of life, with specific characteristics relating to risk factors and management for primary prevention of hypertension in teenage and young adult women; hypertension in pregnancy; hypertension during use of oral contraceptives and assisted reproductive technologies, lactation, menopause, or hormone replacement; hypertension in elderly women; and issues of race and ethnicity. All are detailed in this review, as is information relative to women in clinical trials of hypertension and medication issues. The overarching message is that effective treatment and control of hypertension improves cardiovascular outcomes. But many knowledge gaps persist, including the contribution of hypertensive disorders of pregnancy to cardiovascular disease risk, the role of hormone replacement, blood pressure targets for elderly women, and so on. (c) 2018 the American College of Cardiology Foundation. Published by Elsevier. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available